HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peng Yu Selected Research

Obesity

12/2021Elevated circulating high-sensitivity cardiac troponin t and cardiac remodeling in obesity.
1/2017Serum N1-Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients.
8/2014Rescue of defective MC4R cell-surface expression and signaling by a novel pharmacoperone Ipsen 17.
6/2014Diet-induced obesity drives negative mouse vein graft wall remodeling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peng Yu Research Topics

Disease

79Neoplasms (Cancer)
12/2022 - 01/2008
26Inflammation (Inflammations)
11/2022 - 04/2013
19Cognitive Dysfunction
09/2022 - 01/2012
19Alzheimer Disease (Alzheimer's Disease)
05/2022 - 01/2012
14Reperfusion Injury
05/2022 - 07/2007
13Infections
01/2022 - 11/2011
11Myocardial Ischemia (Ischemic Heart Diseases)
05/2022 - 07/2007
11Heart Failure
01/2022 - 04/2013
10Iron Overload
09/2022 - 01/2011
9Fibrosis (Cirrhosis)
10/2022 - 11/2018
9Neurodegenerative Diseases (Neurodegenerative Disease)
09/2022 - 01/2009
9COVID-19
01/2022 - 11/2020
9Neoplasm Metastasis (Metastasis)
01/2022 - 04/2015
9Stroke (Strokes)
11/2021 - 12/2016
9Myocardial Infarction
01/2021 - 01/2015
9Ischemia
11/2020 - 07/2007
8Breast Neoplasms (Breast Cancer)
09/2022 - 04/2016
8Wounds and Injuries (Trauma)
06/2022 - 01/2013
8Atrial Fibrillation
01/2022 - 01/2020
8Hypoxia (Hypoxemia)
01/2022 - 11/2007
8Osteoporosis
01/2021 - 10/2014
7Pain (Aches)
04/2022 - 08/2009
7Hemorrhage
11/2021 - 02/2009
6Infarction (Infarctions)
05/2022 - 12/2014
6Hypertension (High Blood Pressure)
04/2022 - 04/2013
6Carcinogenesis
04/2022 - 09/2015
6Non-alcoholic Fatty Liver Disease
01/2022 - 01/2019
6Atherosclerosis
01/2022 - 02/2013
6Insulin Resistance
01/2022 - 01/2018
6Iron Deficiencies
01/2021 - 09/2013
6Dementia (Dementias)
03/2016 - 01/2012
6Hyperplasia
02/2016 - 07/2007
5Neuroinflammatory Diseases
05/2022 - 01/2019
5Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2016
5Hepatocellular Carcinoma (Hepatoma)
10/2021 - 08/2016
5Coronary Artery Disease (Coronary Atherosclerosis)
01/2021 - 03/2013
4Spinal Cord Injuries (Spinal Cord Injury)
11/2022 - 01/2015
4Poisoning
03/2022 - 01/2021
4Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 07/2016
4Necrosis
01/2022 - 10/2014
4Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 04/2015
4Obesity
12/2021 - 06/2014
4Lung Neoplasms (Lung Cancer)
02/2021 - 06/2016
4Type 2 Diabetes Mellitus (MODY)
01/2021 - 03/2017
4Brain Diseases (Brain Disorder)
01/2021 - 02/2013
4Human Influenza (Influenza)
11/2020 - 11/2016
4Liver Neoplasms (Liver Cancer)
08/2020 - 04/2016
4Cardiomegaly (Heart Hypertrophy)
01/2020 - 09/2011
4Body Weight (Weight, Body)
01/2020 - 03/2018
4Leukemia
11/2019 - 08/2014
4Cardiomyopathies (Cardiomyopathy)
01/2019 - 01/2009
4Iron-Deficiency Anemia (Anemia, Iron Deficiency)
03/2018 - 12/2014
4Hyperlipidemias (Hyperlipidemia)
03/2017 - 01/2007
3Memory Disorders (Memory Loss)
09/2022 - 10/2020
3Burns
08/2022 - 01/2022
3Mitochondrial Diseases (Mitochondrial Disease)
05/2022 - 12/2017

Drug/Important Bio-Agent (IBA)

32Proteins (Proteins, Gene)FDA Link
09/2022 - 01/2008
26Pharmaceutical PreparationsIBA
12/2022 - 01/2015
24IronIBA
09/2022 - 01/2011
24Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2007
11Amyloid (Amyloid Fibrils)IBA
05/2022 - 01/2014
9Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2017
9CytokinesIBA
01/2022 - 11/2015
9MicroRNAs (MicroRNA)IBA
01/2022 - 04/2015
8HydrogelsIBA
11/2022 - 05/2018
8Biological ProductsIBA
06/2022 - 01/2013
8Therapeutic UsesIBA
01/2022 - 12/2003
8Sevoflurane (Ultane)FDA LinkGeneric
01/2021 - 12/2014
7Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022 - 08/2020
6Adenosine Triphosphate (ATP)IBA
05/2022 - 12/2014
6HMGB1 Protein (HMG1)IBA
01/2022 - 06/2013
6LigandsIBA
01/2022 - 07/2018
6RNA (Ribonucleic Acid)IBA
01/2022 - 11/2014
6EnzymesIBA
12/2021 - 01/2012
6HepcidinsIBA
01/2021 - 01/2011
5Liposomes (Liposome)IBA
09/2022 - 09/2013
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2022 - 11/2007
5Long Noncoding RNAIBA
01/2022 - 01/2020
5PolymersIBA
01/2022 - 11/2018
5Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2012
4VaccinesIBA
08/2022 - 04/2019
4Messenger RNA (mRNA)IBA
01/2022 - 11/2014
4Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 11/2018
4Retinaldehyde (Retinal)IBA
07/2021 - 01/2017
4Anesthetics (Anesthetic Agents)IBA
01/2021 - 10/2019
4salicylhydroxamic acid (SHAM)IBA
11/2020 - 01/2013
4Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
06/2018 - 11/2009
4Apolipoproteins E (ApoE)IBA
03/2017 - 01/2012
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2022 - 11/2021
3Circular RNAIBA
11/2022 - 01/2020
3Cisplatin (Platino)FDA LinkGeneric
06/2022 - 01/2014
3Biocompatible Materials (Biomaterials)IBA
06/2022 - 10/2016
3ApoferritinsIBA
05/2022 - 01/2011
3Paclitaxel (Taxol)FDA LinkGeneric
04/2022 - 10/2021
3Small Interfering RNA (siRNA)IBA
04/2022 - 08/2009
3Peptides (Polypeptides)IBA
02/2022 - 07/2021
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022 - 02/2016
3Angiotensin IIIBA
01/2022 - 08/2012

Therapy/Procedure

35Therapeutics
08/2022 - 03/2008
10Drug Therapy (Chemotherapy)
01/2022 - 10/2016